A survey of clinicians addressing the approach to the management of severe sepsis and septic shock in the United States

Journal of Critical Care

Volumn 25, Issue 4, 2010, Pages 658.e1-658.e6

  Djurkovic, Svetolik ^a   Baracaldo, Juan C ^a   Guerra, Jose A ^a   Sartorius, Jennifer ^a   Haupt, Marilyn T ^a  

^a GEISINGER MEDICAL CENTER   (United States)

Author keywords

Compliance; Guidelines; Sepsis; Surviving sepsis campaign

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; DOPAMINE; DROTRECOGIN; HYPERTENSIVE FACTOR; INFUSION FLUID; LACTIC ACID; NORADRENALIN;

ARTICLE; ARTIFICIAL VENTILATION; BLOOD CULTURE; CENTRAL VENOUS PRESSURE; CLINICAL PRACTICE; DRUG USE; EMERGENCY MEDICINE; GLUCOSE BLOOD LEVEL; HUMAN; INTENSIVE CARE; INTERNAL MEDICINE; INTRAVENOUS ADMINISTRATION; LACTATE BLOOD LEVEL; LOW DRUG DOSE; MEDICAL SOCIETY; PRACTICE GUIDELINE; SEPSIS; SEPTIC SHOCK; SEVERE SEPSIS; UNITED STATES;

EID: 78649392925     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrc.2010.04.005     Document Type: Article

References (23)

1. Angus D.C., Linde-Zwirble W.T., Lidicker J., et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29:1303-1310.
2. Dombrovskiy V.Y., Martin A.A., Sunderram J., et al. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med 2007, 35:1244-1250.
3. Martin G.S., Mannino D.M., Eaton S., et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003, 348:1546-1554.
4. Blanco J., Muriel-Bombin A., Sagredo V., et al. Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study. Crit Care 2008, 12:R158.
5. Dellinger R.P., Carlet J.M., Masur H., et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004, 32:858-873.
6. http://www.ihi.org.
7. Ferrer R., Artigas A., Levy M.M., Blanco J., et al. Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA 2008, 299:2294-2303.
8. Ferrer R., Artigas A., Suarez D., et al. Effectiveness of Treatments for Severe Sepsis: a prospective multicenter observational study. Am J Respir Crit Care Med 2009.
9. Zambon M., Ceola M., Almeida-de-Castro R., et al. Implementation of the Surviving Sepsis Campaign guidelines for severe sepsis and septic shock: we could go faster. J Crit Care 2008, 23:455-460.
10. Cabana M.D., Rand C.S., Powe N.R., et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999, 282:1458-1465.
11. Davis D., O'Brien M.A., Freemantle N., et al. Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes?. JAMA 1999, 282:867-874.
12. Quenot J.P., Mentec H., Feihl F., Annane D., et al. Bedside adherence to clinical practice guidelines in the intensive care unit: the TECLA study. Intensive Care Med 2008, 34:1393-1400.
13. Kalassian K.G., Dremsizov T., Angus D.C. Translating research evidence into clinical practice: new challenges for critical care. Crit Care 2002, 6:11-14.
14. Sinuff T., Cook D., Giacomini M., et al. Facilitating clinician adherence to guidelines in the intensive care unit: a multicenter, qualitative study. Crit Care Med 2007, 35:2083-2089.
15. Shapiro N.I., Howell M.D., Talmor D., et al. Implementation and outcomes of the Multiple Urgent Sepsis Therapies (MUST) protocol. Crit Care Med 2006, 34:1025-1032.
16. Nguyen H.B., Corbett S.W., Steele R., et al. Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality. Crit Care Med 2007, 35:1105-1112.
17. Sprung C.L., Annane D., Keh D., et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008, 358:111-124.
18. Brunkhorst F.M., Engel C., Bloos F., et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008, 358:125-139.
19. Bernard G.R., Vincent J.L., Laterre P.F., et al. Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group: efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001, 344:699-709.
20. Rivers E., Nguyen B., Havstad S., et al. Early Goal-Directed Therapy Collaborative Group: early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345:1368-1377.
21. van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001, 345:1359-1367.
22. The Acute Respiratory Distress Syndrome Network Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000, 342:1301-1308.
23. Brunkhorst F.M., Engel C., Ragaller M., et al. Practice and perception-a nationwide survey of therapy habits in sepsis. Crit Care Med 2008, 36:2719-2725.